Evaluation of entropy and fractal dimension as biomarkers for tumor growth and treatment response using cellular automata
From MaRDI portal
(Redirected from Publication:6174190)
Abstract: Cell-based models provide a helpful approach for simulating complex systems that exhibit adaptive, resilient qualities, such as cancer. Their focus on individual cell interactions makes them a particularly appropriate strategy to study the effects of cancer therapies, which often are designed to disrupt single-cell dynamics. In this work, we also propose them as viable methods for studying the time evolution of cancer imaging biomarkers (IBM). We propose a cellular automata model for tumor growth and three different therapies: chemotherapy, radiotherapy, and immunotherapy, following well-established modeling procedures documented in the literature. The model generates a sequence of tumor images, from which time series of two biomarkers: entropy and fractal dimension, is obtained. Our model shows that the fractal dimension increased faster at the onset of cancer cell dissemination, while entropy was more responsive to changes induced in the tumor by the different therapy modalities. These observations suggest that the predictive value of the proposed biomarkers could vary considerably with time. Thus, it is important to assess their use at different stages of cancer and for different imaging modalities. Another observation derived from the results was that both biomarkers varied slowly when the applied therapy attacked cancer cells in a scattered fashion along the automatons' area, leaving multiple independent clusters of cells at the end of the treatment. Thus, patterns of change of simulated biomarkers time series could reflect on essential qualities of the spatial action of a given cancer intervention.
Recommendations
- Modelling cancer dynamics using cellular automata
- Simulation of tumor response to immunotherapy using a hybrid cellular automata model
- The Use of Hybrid Cellular Automaton Models for Improving Cancer Therapy
- Modelling of killer T-cell and cancer cell subpopulation dynamics under immuno- and chemotherapies
- Tumor growth modelling by cellular automata
Cites work
- `Go or grow': the key to the emergence of invasion in tumour progression?
- A cellular automata model of chemotherapy effects on tumour growth: targeting cancer and immune cells
- A cellular automata model of tumor-immune system interactions
- A quantitative cellular automaton model of in vitro multicellular spheroid tumour growth
- Avascular growth, angiogenesis and vascular growth in solid tumours: The mathematical modelling of the stages of tumour development
- Cellular automaton modeling of tumor invasion
- Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model
- Simulation of tumor response to immunotherapy using a hybrid cellular automata model
Cited in
(2)
This page was built for publication: Evaluation of entropy and fractal dimension as biomarkers for tumor growth and treatment response using cellular automata
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6174190)
